The global clinical trial packaging market has witnessed impressive growth in the past decade, due to growing pharmaceutical packaging products trade across the globe. The demand of clinical trial packaging has witnessed an upstick in the recent past.
麻豆原创 Analysis and Insights: Global Clinical Trial Packaging 麻豆原创
The global Clinical Trial Packaging market is projected to grow from US$ 1004.6 million in 2023 to US$ 1354 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period.
The US & Canada market for Clinical Trial Packaging is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Clinical Trial Packaging is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Clinical Trial Packaging is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Clinical Trial Packaging include Bilcare, Fisher Clinical Services, WuXi AppTec, PCI Pharma Services, Almac Group, PharMaterials, PAREXEL, Schreiner MediPharm and Sharp Packaging, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Clinical Trial Packaging market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Clinical Trial Packaging, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Clinical Trial Packaging, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Clinical Trial Packaging revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Clinical Trial Packaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Clinical Trial Packaging revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bilcare, Fisher Clinical Services, WuXi AppTec, PCI Pharma Services, Almac Group, PharMaterials, PAREXEL, Schreiner MediPharm and Sharp Packaging, etc.
By Company
Bilcare
Fisher Clinical Services
WuXi AppTec
PCI Pharma Services
Almac Group
PharMaterials
PAREXEL
Schreiner MediPharm
Sharp Packaging
The Coghlan Group
Rubicon
Westrock
Xerimis
Catalent
Piramal Pharma Solutions
Corden Pharma
DMB Consultancy
K枚rber Medipak Systems
Sentry BioPharma
NextPharma
Mawdsleys
Segment by Type
Syringes
Vials and Ampoules
Blisters
Tubes
Bottles
Bags and Pouches
Sachets
Kits or Packs
Others
Segment by Application
Drug Manufacturing Companies
Research Laboratories
Clinical Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Clinical Trial Packaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Packaging companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Packaging revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Clinical Trial Packaging 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Syringes
1.2.3 Vials and Ampoules
1.2.4 Blisters
1.2.5 Tubes
1.2.6 Bottles
1.2.7 Bags and Pouches
1.2.8 Sachets
1.2.9 Kits or Packs
1.2.10 Others
1.3 麻豆原创 by Application
1.3.1 Global Clinical Trial Packaging 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Drug Manufacturing Companies
1.3.3 Research Laboratories
1.3.4 Clinical Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Packaging 麻豆原创 Perspective (2018-2029)
2.2 Global Clinical Trial Packaging Growth Trends by Region
2.2.1 Clinical Trial Packaging 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trial Packaging Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Clinical Trial Packaging Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Clinical Trial Packaging 麻豆原创 Dynamics
2.3.1 Clinical Trial Packaging Industry Trends
2.3.2 Clinical Trial Packaging 麻豆原创 Drivers
2.3.3 Clinical Trial Packaging 麻豆原创 Challenges
2.3.4 Clinical Trial Packaging 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Clinical Trial Packaging by Players
3.1.1 Global Clinical Trial Packaging Revenue by Players (2018-2023)
3.1.2 Global Clinical Trial Packaging Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Clinical Trial Packaging 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Clinical Trial Packaging, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Clinical Trial Packaging 麻豆原创 Concentration Ratio
3.4.1 Global Clinical Trial Packaging 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Packaging Revenue in 2022
3.5 Global Key Players of Clinical Trial Packaging Head office and Area Served
3.6 Global Key Players of Clinical Trial Packaging, Product and Application
3.7 Global Key Players of Clinical Trial Packaging, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Packaging Breakdown Data by Type
4.1 Global Clinical Trial Packaging Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Clinical Trial Packaging Forecasted 麻豆原创 Size by Type (2024-2029)
5 Clinical Trial Packaging Breakdown Data by Application
5.1 Global Clinical Trial Packaging Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Clinical Trial Packaging Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trial Packaging 麻豆原创 Size (2018-2029)
6.2 North America Clinical Trial Packaging 麻豆原创 Size by Type
6.2.1 North America Clinical Trial Packaging 麻豆原创 Size by Type (2018-2023)
6.2.2 North America Clinical Trial Packaging 麻豆原创 Size by Type (2024-2029)
6.2.3 North America Clinical Trial Packaging 麻豆原创 Share by Type (2018-2029)
6.3 North America Clinical Trial Packaging 麻豆原创 Size by Application
6.3.1 North America Clinical Trial Packaging 麻豆原创 Size by Application (2018-2023)
6.3.2 North America Clinical Trial Packaging 麻豆原创 Size by Application (2024-2029)
6.3.3 North America Clinical Trial Packaging 麻豆原创 Share by Application (2018-2029)
6.4 North America Clinical Trial Packaging 麻豆原创 Size by Country
6.4.1 North America Clinical Trial Packaging 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Clinical Trial Packaging 麻豆原创 Size by Country (2018-2023)
6.4.3 North America Clinical Trial Packaging 麻豆原创 Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Clinical Trial Packaging 麻豆原创 Size (2018-2029)
7.2 Europe Clinical Trial Packaging 麻豆原创 Size by Type
7.2.1 Europe Clinical Trial Packaging 麻豆原创 Size by Type (2018-2023)
7.2.2 Europe Clinical Trial Packaging 麻豆原创 Size by Type (2024-2029)
7.2.3 Europe Clinical Trial Packaging 麻豆原创 Share by Type (2018-2029)
7.3 Europe Clinical Trial Packaging 麻豆原创 Size by Application
7.3.1 Europe Clinical Trial Packaging 麻豆原创 Size by Application (2018-2023)
7.3.2 Europe Clinical Trial Packaging 麻豆原创 Size by Application (2024-2029)
7.3.3 Europe Clinical Trial Packaging 麻豆原创 Share by Application (2018-2029)
7.4 Europe Clinical Trial Packaging 麻豆原创 Size by Country
7.4.1 Europe Clinical Trial Packaging 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Clinical Trial Packaging 麻豆原创 Size by Country (2018-2023)
7.4.3 Europe Clinical Trial Packaging 麻豆原创 Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Clinical Trial Packaging 麻豆原创 Size (2018-2029)
8.2 China Clinical Trial Packaging 麻豆原创 Size by Type
8.2.1 China Clinical Trial Packaging 麻豆原创 Size by Type (2018-2023)
8.2.2 China Clinical Trial Packaging 麻豆原创 Size by Type (2024-2029)
8.2.3 China Clinical Trial Packaging 麻豆原创 Share by Type (2018-2029)
8.3 China Clinical Trial Packaging 麻豆原创 Size by Application
8.3.1 China Clinical Trial Packaging 麻豆原创 Size by Application (2018-2023)
8.3.2 China Clinical Trial Packaging 麻豆原创 Size by Application (2024-2029)
8.3.3 China Clinical Trial Packaging 麻豆原创 Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Clinical Trial Packaging 麻豆原创 Size (2018-2029)
9.2 Asia Clinical Trial Packaging 麻豆原创 Size by Type
9.2.1 Asia Clinical Trial Packaging 麻豆原创 Size by Type (2018-2023)
9.2.2 Asia Clinical Trial Packaging 麻豆原创 Size by Type (2024-2029)
9.2.3 Asia Clinical Trial Packaging 麻豆原创 Share by Type (2018-2029)
9.3 Asia Clinical Trial Packaging 麻豆原创 Size by Application
9.3.1 Asia Clinical Trial Packaging 麻豆原创 Size by Application (2018-2023)
9.3.2 Asia Clinical Trial Packaging 麻豆原创 Size by Application (2024-2029)
9.3.3 Asia Clinical Trial Packaging 麻豆原创 Share by Application (2018-2029)
9.4 Asia Clinical Trial Packaging 麻豆原创 Size by Region
9.4.1 Asia Clinical Trial Packaging 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Clinical Trial Packaging 麻豆原创 Size by Region (2018-2023)
9.4.3 Asia Clinical Trial Packaging 麻豆原创 Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size (2018-2029)
10.2 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Clinical Trial Packaging 麻豆原创 Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bilcare
11.1.1 Bilcare Company Details
11.1.2 Bilcare Business Overview
11.1.3 Bilcare Clinical Trial Packaging Introduction
11.1.4 Bilcare Revenue in Clinical Trial Packaging Business (2018-2023)
11.1.5 Bilcare Recent Developments
11.2 Fisher Clinical Services
11.2.1 Fisher Clinical Services Company Details
11.2.2 Fisher Clinical Services Business Overview
11.2.3 Fisher Clinical Services Clinical Trial Packaging Introduction
11.2.4 Fisher Clinical Services Revenue in Clinical Trial Packaging Business (2018-2023)
11.2.5 Fisher Clinical Services Recent Developments
11.3 WuXi AppTec
11.3.1 WuXi AppTec Company Details
11.3.2 WuXi AppTec Business Overview
11.3.3 WuXi AppTec Clinical Trial Packaging Introduction
11.3.4 WuXi AppTec Revenue in Clinical Trial Packaging Business (2018-2023)
11.3.5 WuXi AppTec Recent Developments
11.4 PCI Pharma Services
11.4.1 PCI Pharma Services Company Details
11.4.2 PCI Pharma Services Business Overview
11.4.3 PCI Pharma Services Clinical Trial Packaging Introduction
11.4.4 PCI Pharma Services Revenue in Clinical Trial Packaging Business (2018-2023)
11.4.5 PCI Pharma Services Recent Developments
11.5 Almac Group
11.5.1 Almac Group Company Details
11.5.2 Almac Group Business Overview
11.5.3 Almac Group Clinical Trial Packaging Introduction
11.5.4 Almac Group Revenue in Clinical Trial Packaging Business (2018-2023)
11.5.5 Almac Group Recent Developments
11.6 PharMaterials
11.6.1 PharMaterials Company Details
11.6.2 PharMaterials Business Overview
11.6.3 PharMaterials Clinical Trial Packaging Introduction
11.6.4 PharMaterials Revenue in Clinical Trial Packaging Business (2018-2023)
11.6.5 PharMaterials Recent Developments
11.7 PAREXEL
11.7.1 PAREXEL Company Details
11.7.2 PAREXEL Business Overview
11.7.3 PAREXEL Clinical Trial Packaging Introduction
11.7.4 PAREXEL Revenue in Clinical Trial Packaging Business (2018-2023)
11.7.5 PAREXEL Recent Developments
11.8 Schreiner MediPharm
11.8.1 Schreiner MediPharm Company Details
11.8.2 Schreiner MediPharm Business Overview
11.8.3 Schreiner MediPharm Clinical Trial Packaging Introduction
11.8.4 Schreiner MediPharm Revenue in Clinical Trial Packaging Business (2018-2023)
11.8.5 Schreiner MediPharm Recent Developments
11.9 Sharp Packaging
11.9.1 Sharp Packaging Company Details
11.9.2 Sharp Packaging Business Overview
11.9.3 Sharp Packaging Clinical Trial Packaging Introduction
11.9.4 Sharp Packaging Revenue in Clinical Trial Packaging Business (2018-2023)
11.9.5 Sharp Packaging Recent Developments
11.10 The Coghlan Group
11.10.1 The Coghlan Group Company Details
11.10.2 The Coghlan Group Business Overview
11.10.3 The Coghlan Group Clinical Trial Packaging Introduction
11.10.4 The Coghlan Group Revenue in Clinical Trial Packaging Business (2018-2023)
11.10.5 The Coghlan Group Recent Developments
11.11 Rubicon
11.11.1 Rubicon Company Details
11.11.2 Rubicon Business Overview
11.11.3 Rubicon Clinical Trial Packaging Introduction
11.11.4 Rubicon Revenue in Clinical Trial Packaging Business (2018-2023)
11.11.5 Rubicon Recent Developments
11.12 Westrock
11.12.1 Westrock Company Details
11.12.2 Westrock Business Overview
11.12.3 Westrock Clinical Trial Packaging Introduction
11.12.4 Westrock Revenue in Clinical Trial Packaging Business (2018-2023)
11.12.5 Westrock Recent Developments
11.13 Xerimis
11.13.1 Xerimis Company Details
11.13.2 Xerimis Business Overview
11.13.3 Xerimis Clinical Trial Packaging Introduction
11.13.4 Xerimis Revenue in Clinical Trial Packaging Business (2018-2023)
11.13.5 Xerimis Recent Developments
11.14 Catalent
11.14.1 Catalent Company Details
11.14.2 Catalent Business Overview
11.14.3 Catalent Clinical Trial Packaging Introduction
11.14.4 Catalent Revenue in Clinical Trial Packaging Business (2018-2023)
11.14.5 Catalent Recent Developments
11.15 Piramal Pharma Solutions
11.15.1 Piramal Pharma Solutions Company Details
11.15.2 Piramal Pharma Solutions Business Overview
11.15.3 Piramal Pharma Solutions Clinical Trial Packaging Introduction
11.15.4 Piramal Pharma Solutions Revenue in Clinical Trial Packaging Business (2018-2023)
11.15.5 Piramal Pharma Solutions Recent Developments
11.16 Corden Pharma
11.16.1 Corden Pharma Company Details
11.16.2 Corden Pharma Business Overview
11.16.3 Corden Pharma Clinical Trial Packaging Introduction
11.16.4 Corden Pharma Revenue in Clinical Trial Packaging Business (2018-2023)
11.16.5 Corden Pharma Recent Developments
11.17 DMB Consultancy
11.17.1 DMB Consultancy Company Details
11.17.2 DMB Consultancy Business Overview
11.17.3 DMB Consultancy Clinical Trial Packaging Introduction
11.17.4 DMB Consultancy Revenue in Clinical Trial Packaging Business (2018-2023)
11.17.5 DMB Consultancy Recent Developments
11.18 K枚rber Medipak Systems
11.18.1 K枚rber Medipak Systems Company Details
11.18.2 K枚rber Medipak Systems Business Overview
11.18.3 K枚rber Medipak Systems Clinical Trial Packaging Introduction
11.18.4 K枚rber Medipak Systems Revenue in Clinical Trial Packaging Business (2018-2023)
11.18.5 K枚rber Medipak Systems Recent Developments
11.19 Sentry BioPharma
11.19.1 Sentry BioPharma Company Details
11.19.2 Sentry BioPharma Business Overview
11.19.3 Sentry BioPharma Clinical Trial Packaging Introduction
11.19.4 Sentry BioPharma Revenue in Clinical Trial Packaging Business (2018-2023)
11.19.5 Sentry BioPharma Recent Developments
11.20 NextPharma
11.20.1 NextPharma Company Details
11.20.2 NextPharma Business Overview
11.20.3 NextPharma Clinical Trial Packaging Introduction
11.20.4 NextPharma Revenue in Clinical Trial Packaging Business (2018-2023)
11.20.5 NextPharma Recent Developments
11.21 Mawdsleys
11.21.1 Mawdsleys Company Details
11.21.2 Mawdsleys Business Overview
11.21.3 Mawdsleys Clinical Trial Packaging Introduction
11.21.4 Mawdsleys Revenue in Clinical Trial Packaging Business (2018-2023)
11.21.5 Mawdsleys Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bilcare
Fisher Clinical Services
WuXi AppTec
PCI Pharma Services
Almac Group
PharMaterials
PAREXEL
Schreiner MediPharm
Sharp Packaging
The Coghlan Group
Rubicon
Westrock
Xerimis
Catalent
Piramal Pharma Solutions
Corden Pharma
DMB Consultancy
K枚rber Medipak Systems
Sentry BioPharma
NextPharma
Mawdsleys
听
听
*If Applicable.
